Kuano is delighted to welcome Augustin Amour to the company

Kuano is delighted to welcome, Augustin Amour, to the company. Gus will collaborate as a consultant, supporting senior management in our enzymatic franchises. Gus has been with GSK for the past 24 years. There he led laboratory and project teams in R&D. With expertise in immunology and molecular pharmacology, particularly in enzyme inhibitors, he has contributed to over 50 publications and patents. Gus steers industry engagement with academia as the chair of the Biochemical Society's Industry Advisory Panel and advises the EU Openscreen consortium, underscoring his leadership in drug discovery and his commitment to biotechnological collaboration. Gus collaborating with Kuano returns to his roots in Cambridge where he undertook a post-doc after earning a PhD in Biochemistry in Paris.